chrisvoncsefalvay/vaers-outcomes huggingface dataset:
experienced joint pain in opposite arm; a bit of tingling/numbness in my fingers; a bit of tingling/numbness in fingers.; Beginning symptom was just soreness in arm that received the vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. An 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EWO167) via an unspecified route of administration in left arm on 24May2021 at 15:15 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergy to regular laundry detergent or chemicals and short haired animal fur. Concomitant medications included vitamins nos (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and diphenhydramine hydrochloride (BENADRYL) from an unknown date for allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 24May2021 at 16:00, the patient experienced just soreness in arm that received the vaccine and a bit of tingling/numbness in her fingers. On 25May2021, the day after, the patient experienced joint pain in the opposite arm and vaccinated arm felt fine. All symptoms were no longer continued and the patient felt regular. No therapeutic measures were taken as a result of the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness in arm, a bit of tingling/numbness in fingers and joint pain in the opposite arm was recovered on an unknown date in May2021.     No follow-up attempts are possible. No further information is expected.
Thrombocytopenia (CMS/HCC) Hypercalcemia Chronic anemia AKI (acute kidney injury) (CMS/HCC) DKA, type 2 (CMS/HCC)
The day after the vaccine I had extreme soreness that did not go away for 3 weeks that did not go away. There was some muscle twitching in my arm that resolved after a few days.
localized reaction at injection site on right upper arm with erythema and mild pain to palpation.
PATIENT CALLED PHARMACY AND SAID SHE HAS HAD SEVERAL WEEKS OF NUMBNESS IN HER VACCINATED ARM DOWN TO THE FINGERS. SHE ALSO COMPLAINS OF PAIN IN UPPER SHOULDER/CHEST AREA NEAR ARM
This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (Other symptoms post vaccination), HEADACHE (Headache) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNEVALUABLE EVENT (Other symptoms post vaccination), HEADACHE (Headache) and FATIGUE (Fatigue). At the time of the report, UNEVALUABLE EVENT (Other symptoms post vaccination), HEADACHE (Headache) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant and treatment medications were reported; Sender's Comments: Very limited information regarding these events have been provided at this time. No further information is expected.
About 12 hours after injection, sever chills, severe headache, fever of 102.5, body aches and nausea. Left leg pain.
A nurse reported the following information via a company on 12 OCT 2009: A pregnant, female patient was vaccinated i.m. with FLUVIRIN (batch no. unknown) in OCT 2009. No adverse event was reported. Company Ref. no.: NA09-005951. This case was previously recorded as MA2009-2990. Follow-up report received from the nurse on 10 Jan 2011: The patient suffered from miscarriage on an unknown date. Causal relationship between vaccine and miscarriage was assessed as not related. The reporter could not provide any additional information.
4-5hr p/vax pt screamed for approx 4-5hr;t101;inj site red hot & hard;
Hardened, reddened, painful area at injection site the next morning. Fever 101.5 throughout 6-14-18. Nausea, malaise and headache also. On Monday, July 16, 2018, redness, hard feeling and warm to touch at injection site extending to 12 cm L and 10 cm W. Alternated acetaminophen and ibuprofen and applied ice to injection site. First 2 nights the pain made sleeping difficult.
The second dose of GARDASIL 9 was missed for the patient on an unspecified date; The second dose of GARDASIL 9 was missed for the patient on an unspecified date; No adverse affects reported; Information has been received from a medical assistant regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 17-MAY-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, as prophylaxis (strength, frequency, route of administration, anatomical location, lot number and expiration date were not provided). On an unknown date, the patient missed the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (missed dose/incomplete course of vaccination).  No adverse effects were reported.
Started with swelling hands during moderate exercise (3 mile walk). Tingling started in hands shortly thereafter and continues. Secondarily, muscle tightness especially in legs (quads very tight). Coincidentally perhaps is development strained calf muscle during a run. Finally, and related to tingling. I experience my arms "going to sleep" at night depending on which side I'm sleeping on. Summary: Tingling in fingers persists. Arms "going to sleep" at night. Tight muscles (seems to be subsiding)
Patient received Flu vaccine in left deltoid, marked swelling and erythema, tenderness. Swelling about 3cm diameter. Twenty-four hours later with sore throat, burning sensation, felt like airway narrowing. Appeared to inflame the patient's Gastroesophageal Reflux Disease which had been dormant for 6 months. 12/15/08-records received for DOS 10/1-10/2-10/2/08-presented to ED with serum reaction. C/O dysnpnea, rash, swelling of throat. Assessment:acute allergic reaction.  Rhinorrhea.
I had reactions after first and third shot. Started ext. having severe headaches. fatigue, left side of body aching, arm, shoulder pain. After first shot neck area 2 blood vessels sensitive pain full through ears had long recovery. After third shot left side hurting so bad under breast doctor gave me first time symbalta medicine. It helped
Pt came to clinic for vaccines 8/1/23. Pt birthdate was incorrectly entered into system. RN verified birthdate and corrected it in system but did not recalculate pt age. Tdap was given instead of Dtap. Pt mother made aware. Pt to clinic 9/14/23 and given correct vaccines per age and guidelines.
Lethargic; No energy; No appetite; Body aches (big time); Fever (99-100); Chills; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), ASTHENIA (No energy), DECREASED APPETITE (No appetite), PAIN (Body aches (big time)) and PYREXIA (Fever (99-100)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced LETHARGY (Lethargic), ASTHENIA (No energy), DECREASED APPETITE (No appetite), PAIN (Body aches (big time)), PYREXIA (Fever (99-100)) and CHILLS (Chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 07-Feb-2021, LETHARGY (Lethargic), ASTHENIA (No energy), DECREASED APPETITE (No appetite), PAIN (Body aches (big time)), PYREXIA (Fever (99-100)) and CHILLS (Chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow up information received on 12 Jul 2021 contains non significant information
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of liquid PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported. Additional information has been requested.
pt recv vax 4NOV96 & 11NOV96 pt devel a chickenpox-like eruption described as an itchy rash w/less than 50 lesions on chest, back & legs;pt recovered;
Initial information received on 25-Oct-2018 regarding an unsolicited valid non-serious case received from a nurse. This case is linked to cases 2018SA298667, 2018SA298674, 2018SA298672, 2018SA298676, 2018SA298673, 2018SA298677, 2018SA298679 and 2018SA298678, same reporter. This case involves a 51 years old female patient who received vaccine FLUZONE HIGH DOSE. The patient's past medical history, concomitant medication and family history were not provided. On 25-Oct-2018, the patient received a 0.5ml dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot UJ039AA, expiry date 15-May-2019 via intramuscular route in the left arm. It was an actual medication error due to overdose and inappropriate age at vaccine administration. It was reported that 51 years patient was inadvertently administered FLUZONE HIGH DOSE. The patient did not experience any adverse reaction after the injection. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender- none.
Before we left office pt had hives all over body.  Then 3 hours later he had fever of 104. We went back to Dr. Office Dr said this can happen. He continue to run fever for 5 days up to 105. Any time advil wore off fever would spike.
This spontaneous report as received from a pharmacy technician refers to a 1 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 08-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
patient got tingling on lips and had onset of asthma 24 hours after shot. she has had asthma a long time ago but not active until getting the vaccine and continues to have troubled breathing even 14 days  after getting the shot. kidney and lungs hurt and severe headache. got racing heart and left ear swelled up.
Reported redness, swelling, pain, and itching to right arm vaccination site. Noticed the morning after injection.  Took Benadryl for a few days after injection.  As of 11/1/22, symptoms have improved, but still present, especially the itching.
Difficulty breathing 05/15/2001, went to ED-Not thought to be related to injection. On 05/04/2001 had fever and vomiting. Had lesion 2 cm and worsened on 5/15 to size it is now. Reaction on right arm at injection site with 7 cm large swollen, red area.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was not provided. On an unknown date, the patient was vaccinated with an improperly stored dose of oral, ROTATEQ lot # L008054 with expiration date 30-NOV-2016 or lot # L013192 with expiration date 19-JAN-2017 (it was unspecified which lot was administered) (dose and route of administration were not reported). No adverse effects reported. This is one of two reports from the same source. Additional information is not expected as no consent for further contact was given.
Vesiculobullous dermatitis-generalized within a couple of days after vaccine (does not indicate on form the date that the adverse event started; assumed 'a couple of days' to be two days after vaccination). Pruritic varicella form is character.
pt recvd vax; devel diarrhea & hypothermia of 92; 2dec93 no response to request for more information;
Wife of patient reported numbness on side of face and part of tongue, late last night and still numb today.
Fever, chills so severe; Fever, chills so severe; Body pain lasted 48 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: PYREXIA (non-serious), CHILLS (non-serious), outcome "unknown" and all described as "Fever, chills so severe"; PAIN (non-serious), outcome "recovered", described as "Body pain lasted 48 hours". Therapeutic measures were taken as a result of pyrexia, chills.  Additional information: Clinical course: It was reported that patient second covid vaccine and booster were what would call severe. Fever, chills so severe had 4 layers plus a winter coat and heating pad. Body pain lasted 48 hours. For the 4th booster, patient switched to Moderna and lost another two days with a worse reaction. Patient legs cramped and were so weak, struggled to get of the toilet. If there are no breathing problems, it's all dismissed. Patient know another booster will come in the future.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
5 year old M or F patient complains of a 1 day history of:  rash s/p immunizations yesterday: Dtap, MMR, polio, Chicken Pox.  rash at site diffuse redness about 6 x 3" wrapping medially around thigh.  smaller erythema at other R lateral thigh site 1" diameter
Patient experienced arm pain after vaccine; patient did not seek medical treatment or contact doctor; patient stated arm was getting better when calling 1 day later
Patient received influenza vaccine at different pharmacy locaton Sept 9. Came to Pharmacy for shingles Oct 6th. Technician gave informed consent form to a pharmacist to enter, but did not tell pharmacist it was for a shingles shot. Pharmacist assumed influenza and insurance paid. Pharmacist administering vaccine asked if patient had tolerated flu shots in the past. Patient indicated 'yes,' but did not indicate she was there for a shingles shot. Patient asked about follow up vaccine and pharmacist said not necessary with influenza, which is the point at which the error was noted. Counseled patient regarding duplication and gave correct vaccine (Shingrix) in left arm as well, per patient request. Patient had few symptoms from shot in Sept, unlikely flu this month will give greater symptoms, but counseled that shingles may, as it tends to have stronger local reaction than some other vaccines.
After being vaccinated the pt subsequently experienced mild chickenpox. Another group was reported with chickenpox following vaccination.
(L) arm redness, swelling from shoulder to antecubital space. Arm warm.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent or historical condition was not provided. Between 17-MAR-2016 and 14-JUN-2016 the patient received a dose of improperly stored PNEUMOVAX 23 (lot # L014420 with expired date 23-FEB-2017, strength, dose, frequency, route unknown). Concomitant therapy was not provided. The vaccine was stored under 33F for 112 hours. Previous excursion included 48F for 48 hours and 33 F for 120 hours. Data logger was not involved. No adverse effects reported. Additional information has been requested.
Approximately 5-10 minutes after receiving the MMR and varicella vax, the pt complained of feeling hot, flushing, throat burning and intense itching. Decreased blood pressure at 84/50, nausea and vomiting and diaphoresis. Was transported to the ER for monitoring, IV and evaluation.
15min after receiving the vaccine I felt chills on the right side of my body and muscle soreness in arm spreading up to right side of neck.  10hrs after receiving the vaccine I developed a headache that lasted for 72hrs and wasn't relieved by Tylenol.  I began running a fever of 101F, muscle and joint aches, chills, sweating that soaked by bedding that lasted for 48hrs.  Four days after the injection, I   noticed my legs from knee down were swollen for 36hrs.   I also experienced by heartbeat racing for 48hrs that began 10hrs after the injection.
Presented to ER on 1/7/22 and was admitted.  Present to ED from nursing home with chief complaint of altered mental status, patient is only oriented to himself and unable to get  the information.  Most of the informations from ED provider and nursing home record,  ED patient was afebrile, blood pressure stable, saturation 90 percent on room air. Regarding labs COVID positive, ABG showed pH 7.42, pCO2 33, PO2 60/92, WBC 19, CRP 320, procalcitonin 25, ESR 57, creatinine 2.8, phosphate 6.2, troponin 1310 ng/ liter. U tox, negative, BNP, CT Findings suggest a small bowel obstruction complicated by bowel ischemia and secondary bowel infarction with pneumatosis and small bowel mesenteric venous air. Placed on zosyn and doxycycline. Was on Room air and placed on comfort measures. Discharged on 1/12/22 to hospice.
received a dose of expired MENACTRA today with no reported adverse event; Initial information received on 22-Apr-2022 regarding an unsolicited valid  non-serious case received from a other health care professional.  This case involves an unknown age and unknown gender patient who  received a dose of expired menactra today with no reported adverse event while receiving  Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 22-Apr-2022, the patient received a  dose of suspect Meningococcal A-C-Y-W135 (D Conj) Vaccine  (lot number: U6921AB ,Expiration date : 17-Apr-2022)(strength, formulation, dosage, route, administration site :unknown for the suspect)  for immunization.  On an unknown date the patient developed non-serious sevent received a dose of expired menactra today with no reported adverse event (expired product administered) (unknown latency) following the administration of Meningococcal A-C-Y-W135 (D Conj) Vaccine.  Action taken : not applicable.  It was not reported if the patient received a corrective treatment for the event (received a dose of expired MENACTRA today with no reported adverse event).  At time of reporting, the outcome was Unknown for the event received a dose of expired menactra today with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
No adverse event; Patient received a 0.5mL dose of the Moderna COVID-19 vaccine bivalent; This spontaneous case was reported by a nurse and describes the occurrence of OVERDOSE (Patient received a 0.5mL dose of the Moderna COVID-19 vaccine bivalent) and NO ADVERSE EVENT (No adverse event) in a 9-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 010H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 vaccine (Dose 1) on 29-Oct-2021 and Pfizer COVID-19 vaccine (Dose 2) on 09-Nov-2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine and Pfizer COVID-19 vaccine.    On 17-Nov-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 17-Nov-2022, the patient experienced OVERDOSE (Patient received a 0.5mL dose of the Moderna COVID-19 vaccine bivalent). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, OVERDOSE (Patient received a 0.5mL dose of the Moderna COVID-19 vaccine bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for OVERDOSE (Patient received a 0.5mL dose of the Moderna COVID-19 vaccine bivalent).    No concomitant medications were reported. No additional doses were reported. No symptoms were reported. No treatment information was provided.
pt stated that his gout flared up the next morning and his feet were swollen and it lasted about 6 days
w/in 24hr of vax pt devel a fever as high as 102 infants recv unspecified tx & recovered;
Day of shot: Very tired, fatigue, sore arm at injection site Day 2: Extreme indigestion, constant burping, acid reflux, heartburn,  sore arm at injection site Day 3-6: Fatigue, Sore to touch arm, Extreme indigestion, had to take Gas-X 2 times a day and still couldn't eat much due to discomfort, heart pounds hard without exertion various times throughout day (lasting 5-15 min at a time, 3-5 times a day) Day 7: Migraine on right side of head into ear and jaw (NOT prone to migraines, only had 1 prior in entire life), jaw pain,  fatigue, lasted 2 hours with residual jaw pain the next day, Extreme indigestion, had to take Gas-X 2 times a day  Day 8: Fatigue went away, arm still sore to touch, Extreme indigestion, had to take Gas-X 2 times a day  Day 9: Heart raced randomly, heart pounds hard without exertion, 1 heart palpitation, arm still sore to touch, Extreme indigestion, had to take Gas-X 2 times a day  Day 11: Arm itches and hurts worse, take 1 benadryl a day and a tylenol both at night before bed, indigestion goes away Day 12: Arm itches and hurts, top of shoulder hurts Heart continues to pound randomly through day 19 of vaccine Got vaccine on day 20 of menstrual cycle, started period day Day 30 but had exceptionally light bleeding